Recent updates of transarterial chemoembolilzation in hepatocellular carcinoma
Y Chang, SW Jeong, J Young Jang… - International journal of …, 2020 - mdpi.com
Transarterial chemoembolization (TACE) is a standard treatment for intermediate-stage
hepatocellular carcinoma (HCC). In this review, we summarize recent updates on the use of …
hepatocellular carcinoma (HCC). In this review, we summarize recent updates on the use of …
[HTML][HTML] 2018 Korean Liver Cancer Association–National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma
Korean Liver Cancer Association - Korean Journal of Radiology, 2019 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular …
V Vilgrain, H Pereira, E Assenat, B Guiu… - The Lancet …, 2017 - thelancet.com
Background Sorafenib is the recommended treatment for patients with advanced
hepatocellular carcinoma. We aimed to compare the efficacy and safety of sorafenib to that …
hepatocellular carcinoma. We aimed to compare the efficacy and safety of sorafenib to that …
High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating …
B Yang, X Feng, H Liu, R Tong, J Wu, C Li, H Yu… - Oncogene, 2020 - nature.com
Exosomes play an important role in intercellular communication and metastatic progression
of hepatocellular carcinoma (HCC). However, cellular communication between …
of hepatocellular carcinoma (HCC). However, cellular communication between …
CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA
Background CD90+ liver cancer cells have been described as cancer stem-cell-like (CSC),
displaying aggressive and metastatic phenotype. Using two different in vitro models, already …
displaying aggressive and metastatic phenotype. Using two different in vitro models, already …
[HTML][HTML] 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Korean Liver Cancer Association - Korean Journal of Radiology, 2022 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …
Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma
S Culleton, H Jiang, CR Haddad, J Kim… - Radiotherapy and …, 2014 - Elsevier
Purpose To report outcomes in patients with Child-Pugh B or C (CP B/C) hepatocellular
carcinoma (HCC) treated with stereotactic body radiotherapy (SBRT). Methods and …
carcinoma (HCC) treated with stereotactic body radiotherapy (SBRT). Methods and …
[PDF][PDF] Taurine up‐regulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma
YH Lin, MH Wu, YH Huang, CT Yeh, ML Cheng… - …, 2018 - Wiley Online Library
Cancer cells display altered glucose metabolism characterized by a preference for aerobic
glycolysis. The aerobic glycolytic phenotype of hepatocellular carcinoma (HCC) is often …
glycolysis. The aerobic glycolytic phenotype of hepatocellular carcinoma (HCC) is often …
The significance of classifying microvascular invasion in patients with hepatocellular carcinoma
S Sumie, O Nakashima, K Okuda, R Kuromatsu… - Annals of surgical …, 2014 - Springer
Background Microvascular invasion (MVI) has been recognized as a risk factor for outcome
following curative resection in hepatocellular carcinoma (HCC). Because MVI can range …
following curative resection in hepatocellular carcinoma (HCC). Because MVI can range …
2018 Korean Liver Cancer Association-National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …